-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-582 in Angelman Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-582 in Angelman Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-582 in Angelman SyndromeDrug Details:ION-582 is under development for the treatment of Angelman...
-
Thematic Analysis
Batteries in Aerospace and Defense – Thematic Intelligence
Batteries in Aerospace and Defense Thematic Report Overview In the coming decades, advancements in energy storage and batteries will play a critical role in the future of aerospace, defense, and security. The development of electric military vehicles, electric aircraft, electric vertical take-off and landing (eVTOL) aircraft, and other electronics will have a sizable impact on warfare. Meanwhile, China’s control of the entire global supply chain, from mines and refiners to component markers and cell producers, is a mounting geopolitical issue....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-541 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-541 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-541 in Amyotrophic Lateral Sclerosis Drug Details: ION-541 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bremelanotide Acetate in Diabetic Nephropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bremelanotide Acetate in Diabetic Nephropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bremelanotide Acetate in Diabetic Nephropathy Drug Details: Bremelanotide acetate (Vyleesi) is...
-
Track & Monitor
Batteries in automotive: Li-ion secondary battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Li-ion secondary battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Batteries in automotive: Mixed-metal oxide Li-ion battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Mixed-metal oxide Li-ion battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Fuel cells in automotive: Fuel cell ion exchange membranes
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Fuel cell ion exchange membranes segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-464 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-464 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-464 in Multiple System Atrophy...